柳叶刀 1990-2017年195个国家的全球、区域和国家的胃癌负担研究.pdfVIP

Articles The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 GBD 2017 Stomach Cancer Collaborators* Summary Lancet Gastroenterol Hepatol Background Stomach cancer is a major health problem in many countries. Understanding the current burden of 2020; 5: 42–54 stomach cancer and the differential trends across various locations is essential for formulating effective preventive Published Online strategies. We report on the incidence, mortality, and disability-adjusted life-years (DALYs) due to stomach cancer in October 21, 2019 195 countries and territories from 21 regions between 1990 and 2017. /10.1016/ S2468-1253(19)30328-0 This online publication has Methods Estimates from GBD 2017 were used to analyse the incidence, mortality, and DALYs due to stomach cancer been corrected. The corrected at the global, regional, and national levels. The rates were standardised to the GBD world population and reported per version first appeared at 100 000 population as age-standardised incidence rates, age-standardised death rates, and age-standardised DALY /gastrohep on rates. All estimates were generated with 95% uncertainty intervals (UIs). Feb 12, 2020 See Comment page 5 Findings In 2017, more than 1·22 million (95% UI 1·19–1·25) incident cases of stomach cancer occurred worldwide, *Collaborators listed at the end of the Article and nearly 865 000 people (848 000–885 000) died of stomach cancer, contributing to 19·1 million (18·7–19·6) DALYs. The highest age-standardised incidence rates in 2017 were seen in the high-income Asia Pacifi